PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Transfusion Safety Laboratory, Banc de Sang i Teixits, Servei Català de la Salut, Barcelona, Spain.\', \'Progenika Biopharma, A Grifols company, Derio, Spain.\', \'Grifols Diagnostic Solutions Inc., San Diego, CA, USA.\', \'Microbiology Department, Hospital Universitari Vall d\'Hebron, Barcelona, Spain.\', \'Grifols Movaco, S.A. Barcelona, Spain.\', \'Donostia University Hospital-Biodonostia Health Research Institute, Donostia-San Sebastian, Spain.\', \'Grifols Diagnostic Solutions Inc., San Diego, CA, USA. Electronic address: Jeffrey.linnen@grifols.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0732-8893(21)00252-210.1016/j.diagmicrobio.2021.115560
?:doi
?:hasPublicationType
?:journal
  • Diagnostic microbiology and infectious disease
is ?:pmid of
?:pmid
?:pmid
  • 34688036
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.157
?:rankingScore_hIndex
  • 86
?:title
  • Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated system.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34688036>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34688036>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all